Inventor · disambiguated record
Xiaodong Cheng
Also filed as: CHENG XIAODONG
10 granted patents·8 pending applications·7 citations·filing 2003–2024
81Inventor score
Files withEUCURE BEIJING BIOPHARMA CO LTD9CHENG XIAODONG2UNIV TEXAS2BIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD1GONG BIN1
Top patents by PatentIndex Score
18 records- 0189US10934365B2Anti-OX40 antibodies and uses thereofEUCURE BEIJING BIOPHARMA CO LTD·Filed 2020·Granted Mar 2, 2021·2 cites·25 claims
- 0282US11034764B2Anti-CTLA4 antibodies and uses thereofEUCURE BEIJING BIOPHARMA CO LTD·Filed 2020·Granted Jun 15, 2021·1 cites·18 claims
- 0380US2025034256A1Anti-pd-1 antibodies and uses thereofEUCURE BEIJING BIOPHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0479US2024343806A1Anti-ctla4 antibodies and uses thereofEUCURE BEIJING BIOPHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0578US2024352141A1Anti-ox40 antibodies and uses thereofEUCURE BEIJING BIOPHARMA CO LTD·Filed 2024·Application pending·0 cites
- 0673US7897340B2Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic markerUNIV TEXAS·Filed 2007·Granted Mar 1, 2011·1 cites·11 claims
- 0768US9458131B2Compounds and compositions used to epigenetically transform cells and methods related theretoYOON YOUNG-SUP·Filed 2012·Granted Oct 4, 2016·2 cites·11 claims
- 0867US12054547B2Anti-CTLA4 antibodies and uses thereofEUCURE BEIJING BIOPHARMA CO LTD·Filed 2021·Granted Aug 6, 2024·0 cites·18 claims
- 0967US11999790B2Anti-OX40 antibodies and uses thereofEUCURE BEIJING BIOPHARMA CO LTD·Filed 2021·Granted Jun 4, 2024·0 cites·17 claims
- 1067US2021403570A1Anti-pd-1 antibodies and uses thereofEUCURE BEIJING BIOPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1165US11155625B2Anti-PD-1 antibodies and uses thereofEUCURE BEIJING BIOPHARMA CO LTD·Filed 2020·Granted Oct 26, 2021·0 cites·43 claims
- 1264US9539256B2Modulators of exchange proteins directly activated by cAMP (EPACS)UNIV TEXAS·Filed 2013·Granted Jan 10, 2017·1 cites·21 claims
- 1358US2007178523A1Novel druggable regions in set domain proteins, and methods of using the sameUNIV EMORY·Filed 2003·Application pending·0 cites
- 1447US11124489B2EPAC antagonistsZHOU JIA·Filed 2018·Granted Sep 21, 2021·0 cites·8 claims
- 1546US2014348853A1Methods of treating rickettsia using exchange proteins directly activated by camp (epacs) inhibitorsGONG BIN·Filed 2014·Application pending·0 cites
- 1644US2021269525A1ANTI-CD3e ANTIBODIES AND USES THEREOFBIOCYTOGEN PHARMACEUTICALS BEIJING CO LTD·Filed 2019·Application pending·0 cites
- 1740US9737512B2Methods and compositions for treating chronic painCHENG XIAODONG·Filed 2016·Granted Aug 22, 2017·0 cites·12 claims
- 1833US2010035945A1Small molecule inhibitors of bacterial dam dna methyltransferasesCHENG XIAODONG·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiaodong Cheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →